Global Cell-Based Ophthalmic Therapies Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Cell-Based Ophthalmic Therapies Global Market Report 2025

Name: Cell-Based Ophthalmic Therapies Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy Type (Stem Cell Therapy, Gene Therapy, Tissue Engineering), By Application (Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications), By End-User (Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cell-Based Ophthalmic Therapies Market Overview

• Cell-Based Ophthalmic Therapies market size has reached to $1.22 billion in 2024

• Expected to grow to $3.14 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%

• Growth Driver: Increasing Prevalence Of Ophthalmic Disorders Fueling The Growth Of The Market Due To Rising Vision Impairment Burden

• Market Trend: Breakthrough Allogeneic Cell Therapy Advances Treatment For Corneal Endothelial Diseases

• North America was the largest region in 2024.

What Is Covered Under Cell-Based Ophthalmic Therapies Market?

Cell-based ophthalmic therapies are treatments for eye diseases that use living cells to repair, replace, or protect damaged ocular tissues. They target eye conditions that are difficult to treat with conventional methods by encouraging tissue repair and improving eye function. They provide promising, lasting solutions for vision impairment and enhance patients’ eyesight and overall quality of life through innovative regenerative medicine.

The main types of cell-based ophthalmic therapies are stem cell therapy, gene therapy, and tissue engineering. Stem cell therapy is a medical treatment that uses stem cells to repair, replace, or regenerate damaged or diseased tissues and organs in the body. It is used in various applications such as retinal disorders, corneal disorders, glaucoma, and others, and also used by various end users such as hospitals, ophthalmic clinics, research institutes, and others.

Cell-Based Ophthalmic Therapies Market Size and growth rate 2025 to 2029: Graph

What Is The Cell-Based Ophthalmic Therapies Market Size 2025 And Growth Rate?

What Is The Cell-Based Ophthalmic Therapies Market Growth Forecast?

The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.14 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to growing success in cell therapies, rising healthcare spending globally, an increasing geriatric patient population, a growing pipeline of innovative products, and increasing use of stem cells. Major trends in the forecast period include advancement in stem cell and gene editing technologies, development of targeted drug delivery systems, innovation in regenerative medicine to restore retinal and corneal tissues, advancement in biomaterials enhancing cell therapy efficacy and safety, and development of global collaborations.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Cell-Based Ophthalmic Therapies Market Segmented?

1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering

2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications

3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users

Subsegment:

1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy

3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs

What Is Driving The Cell-Based Ophthalmic Therapies Market? Increasing Prevalence Of Ophthalmic Disorders Fueling The Growth Of The Market Due To Rising Vision Impairment Burden

The increasing prevalence of ophthalmic disorders is expected to propel the growth of the cell-based ophthalmic therapies market going forward. Ophthalmic disorders refer to diseases or conditions impacting the eyes, that create vision problems or damage to eye health. Ophthalmic disorders are on the rise as the aging population faces a greater risk of age-related eye diseases, resulting to vision impairment with longer life expectancy. Cell-based ophthalmic therapies repair or replace damaged retinal and eye cells to restore vision and prevent further damage while promoting regeneration and enhancing overall eye function. For instance, in September 2023, according to the Association of Optometrists, a UK-based representative membership organization, England recorded 22,552 new vision impairment certifications in 2022, including 1,344 from diabetic eye disease, 3,614 from glaucoma, and 10,865 from age-related macular degeneration. Therefore, the increasing prevalence of ophthalmic disorders is driving the growth of the cell-based ophthalmic therapies industry.

Who Are The Major Players In The Global Cell-Based Ophthalmic Therapies Market?

Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., ActualEyes Inc., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.

What Are The Key Trends Of The Global Cell-Based Ophthalmic Therapies Market? Breakthrough Allogeneic Cell Therapy Advances Treatment For Corneal Endothelial Diseases

Major companies operating in the cell-based ophthalmic therapies market are focusing on developing advanced treatments, such as allogeneic cell therapy, to address unmet needs in treating corneal endothelial diseases. Allogeneic cell therapy refers to a treatment that uses stem cells or other cells donated by a genetically different individual of the same species to repair or replace damaged tissues or treat diseases. For instance, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. It is designed for the treatment of bullous keratopathy, a debilitating condition of the corneal endothelium. Vyznova is believed to be the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, having secured both regulatory and reimbursement approvals in Japan.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cell-Based Ophthalmic Therapies Market? Alcon Inc. Acquired Aurion Biotech Inc. To Advance Cell Therapy for Corneal Edema

In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired a majority interest in Aurion Biotech, Inc. for an undisclosed amount. With this acquisition, Alcon aims to advance Aurion Biotech’s clinical-stage allogeneic cell therapy, AURN001, into Phase 3 development for treating corneal edema secondary to corneal endothelial disease, while expanding its ophthalmic pharmaceutical portfolio. Aurion Biotech Inc. is a US-based clinical-stage company developing advanced cell therapies to treat eye diseases.

What Is The Regional Outlook For The Global Cell-Based Ophthalmic Therapies Market?

North America was the largest region in the cell-based ophthalmic therapies market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell-Based Ophthalmic Therapies Market?

The cell-based ophthalmic therapies market consists of revenues earned by entities by providing services such as clinical trial services, ocular cell therapy consultation, post-therapy monitoring and support, research and development services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-based ophthalmic therapies market also includes sales of neural progenitor cell injections, bioengineered retinal pigment epithelium scaffolds, autologous mesenchymal stem cell grafts, and ex-vivo expanded conjunctival epithelial cell sheets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell-Based Ophthalmic Therapies Industry?

The cell-based ophthalmic therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell-based ophthalmic therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cell Based Ophthalmic Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.48 billion
Revenue Forecast In 2034	$3.14 billion
Growth Rate	CAGR of 20.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Therapy Type, Application, End-User, Stem Cell Therapy, Gene Therapy, Tissue Engineering
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., ActualEyes Inc., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cell-Based Ophthalmic Therapies Market Characteristics

3. Cell-Based Ophthalmic Therapies Market Trends And Strategies

4. Cell-Based Ophthalmic Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Based Ophthalmic Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Cell-Based Ophthalmic Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cell-Based Ophthalmic Therapies Market Growth Rate Analysis

5.4. Global Cell-Based Ophthalmic Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cell-Based Ophthalmic Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cell-Based Ophthalmic Therapies Total Addressable Market (TAM)

6. Cell-Based Ophthalmic Therapies Market Segmentation

6.1. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stem Cell Therapy

Gene Therapy

Tissue Engineering

6.2. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retinal Disorders

Corneal Disorders

Glaucoma

Other Applications

6.3. Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ophthalmic Clinics

Research Institutes

Other End-Users

6.4. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Embryonic Stem Cell Therapy

Mesenchymal Stem Cell Therapy

Induced Pluripotent Stem Cell Therapy

Retinal Pigment Epithelium Cell Therapy

Limbal Stem Cell Therapy

6.5. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vector Based Gene Therapy

Non-Viral Vector Based Gene Therapy

In-Vivo Gene Therapy

Ex-Vivo Gene Therapy

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy

6.6. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bioengineered Corneal Tissue

Amniotic Membrane Transplantation

Hydrogel-Based Scaffolds

Synthetic Polymer Scaffolds

Decellularized Tissue Constructs

7. Cell-Based Ophthalmic Therapies Market Regional And Country Analysis

7.1. Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Based Ophthalmic Therapies Market

8.1. Asia-Pacific Cell-Based Ophthalmic Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Based Ophthalmic Therapies Market

9.1. China Cell-Based Ophthalmic Therapies Market Overview

9.2. China Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Based Ophthalmic Therapies Market

10.1. India Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Based Ophthalmic Therapies Market

11.1. Japan Cell-Based Ophthalmic Therapies Market Overview

11.2. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Based Ophthalmic Therapies Market

12.1. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Based Ophthalmic Therapies Market

13.1. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Based Ophthalmic Therapies Market

14.1. South Korea Cell-Based Ophthalmic Therapies Market Overview

14.2. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Based Ophthalmic Therapies Market

15.1. Western Europe Cell-Based Ophthalmic Therapies Market Overview

15.2. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Based Ophthalmic Therapies Market

16.1. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Based Ophthalmic Therapies Market

17.1. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Based Ophthalmic Therapies Market

18.1. France Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Based Ophthalmic Therapies Market

19.1. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Based Ophthalmic Therapies Market

20.1. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Based Ophthalmic Therapies Market

21.1. Eastern Europe Cell-Based Ophthalmic Therapies Market Overview

21.2. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Based Ophthalmic Therapies Market

22.1. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Based Ophthalmic Therapies Market

23.1. North America Cell-Based Ophthalmic Therapies Market Overview

23.2. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Based Ophthalmic Therapies Market

24.1. USA Cell-Based Ophthalmic Therapies Market Overview

24.2. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Based Ophthalmic Therapies Market

25.1. Canada Cell-Based Ophthalmic Therapies Market Overview

25.2. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Based Ophthalmic Therapies Market

26.1. South America Cell-Based Ophthalmic Therapies Market Overview

26.2. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Based Ophthalmic Therapies Market

27.1. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Based Ophthalmic Therapies Market

28.1. Middle East Cell-Based Ophthalmic Therapies Market Overview

28.2. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Based Ophthalmic Therapies Market

29.1. Africa Cell-Based Ophthalmic Therapies Market Overview

29.2. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Based Ophthalmic Therapies Market Competitive Landscape And Company Profiles

30.1. Cell-Based Ophthalmic Therapies Market Competitive Landscape

30.2. Cell-Based Ophthalmic Therapies Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sumitomo Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Based Ophthalmic Therapies Market Other Major And Innovative Companies

31.1. Healios K.K.

31.2. Lineage Cell Therapeutics

31.3. Pandorum Technologies Pvt. Ltd.

31.4. ActualEyes Inc.

31.5. Neurotech Pharmaceuticals Inc.

31.6. Coave Therapeutics SAS

31.7. jCyte Inc.

31.8. Eyestem Research Pvt. Ltd.

31.9. Opsis Therapeutics

31.10. Regenerative Patch Technologies LLC

31.11. Emmetrope Ophthalmics LLC

31.12. GenSight Biologics S.A.

31.13. MEDIPOST Co. Ltd.

31.14. Riken

31.15. Luxa Biotechnology Inc.

32. Global Cell-Based Ophthalmic Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Based Ophthalmic Therapies Market

34. Recent Developments In The Cell-Based Ophthalmic Therapies Market

35. Cell-Based Ophthalmic Therapies Market High Potential Countries, Segments and Strategies

35.1 Cell-Based Ophthalmic Therapies Market In 2029 - Countries Offering Most New Opportunities

35.2 Cell-Based Ophthalmic Therapies Market In 2029 - Segments Offering Most New Opportunities

35.3 Cell-Based Ophthalmic Therapies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: F. Hoffmann-La Roche Ltd. Financial Performance

Table 78: Bayer AG Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Astellas Pharma Inc. Financial Performance

Table 81: Sumitomo Pharma Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 78: Bayer AG Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Astellas Pharma Inc. Financial Performance

Figure 81: Sumitomo Pharma Co. Ltd. Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Specialty Breathable Membranes Global Market Report 2025 – By Type (Polyurethane, Polytetrafluoroethylene (PTFE), Thermoplastic Polyester, Thermoplastic Elastomers, Polyether Block Amide, Copolyamide), By Distribution Ch...

Vacuum Insulation Global Market Report 2025 – By Type (Flat Panel, Special Shape Panel), By Raw Material (Plastics, Metals), By Core Material (Silica, Fiberglass, Other Core Materials), By End-User Industry (Construction...

Cold Insulation Global Market Report 2025 – By Material Type (Fiber Glass, Polyurethane Foam, Polystyrene Foam, Phenolic Foam, Other Materials), By Insulation Type (Fibrous, Cellular, Granular), By End-Use Industry Type ...

Insulation Products Global Market Report 2025 - By Insulation Type (Thermal, Acoustic, Other Insulation Types), By Material Type (Mineral Wool, Fiberglass, Stone Wool, Polyurethane Foam, Flexible Elastomeric Foam, Other ...

Tank Insulation Global Market Report 2025 – By Type (Storage Tank Insulation, Transportation Tank Insulation), By Material (PU And PIR, Rockwool, Fiberglass, Elastomeric Foam, Cellular Glass, EPS, Other Materials), By Te...

Gas Separation Membrane Global Market Report 2025 – By Product Type (Polyimide And Polyaramid, Polysulfide, Cellulose Acetate, Other Products), By Module (Hollow Fiber, Spiral Wound, Plate And Frame, Other Modules), By A...

Technical Insulation Global Market Report 2025 – By Product (Flexible Foam, Rigid Foam, Man-made Mineral Fiber ), By Application (Heating & Plumbing, HVAC, Refrigeration, Industrial Processes), By End User (Industrial & ...

Frequently Asked Questions

What is the definition of the Cell Based Ophthalmic Therapies market?

How will the Cell Based Ophthalmic Therapies market drivers and restraints affect the market dynamics? What forces will shape the Cell Based Ophthalmic Therapies industry going forward?

The market major growth driver - Increasing Prevalence Of Ophthalmic Disorders Fueling The Growth Of The Market Due To Rising Vision Impairment Burden. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Cell Based Ophthalmic Therapies market?

The cell-based ophthalmic therapies market size has grown exponentially in recent years. It will grow from $1.22 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 21.1%. The growth in the historic period can be attributed to the rising prevalence of eye disorders, increasing demand for vision restoration, growing adoption of regenerative medicine, rising cases of age-related degeneration, and increasing clinical trial investments. The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.14 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to growing success in cell therapies, rising healthcare spending globally, an increasing geriatric patient population, a growing pipeline of innovative products, and increasing use of stem cells. Major trends in the forecast period include advancement in stem cell and gene editing technologies, development of targeted drug delivery systems, innovation in regenerative medicine to restore retinal and corneal tissues, advancement in biomaterials enhancing cell therapy efficacy and safety, and development of global collaborations. For further insights on this market, request a sample here

How is the Cell Based Ophthalmic Therapies market segmented?

The cell-based ophthalmic therapies market covered in this report is segmented
1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering
2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications
3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users Subsegment:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy
3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs For further insights on this market, request a sample here

Which region has the largest share of the Cell Based Ophthalmic Therapies market? What are the other regions covered in the report?

North America was the largest region in the cell-based ophthalmic therapies market in 2024. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Cell Based Ophthalmic Therapies market?

What are the key trends in the Cell Based Ophthalmic Therapies market?

Major trends in this market include Breakthrough Allogeneic Cell Therapy Advances Treatment For Corneal Endothelial Diseases. For further insights on this market, request a sample here.